Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 197K) PPT slides of all figures Supplemental Material Index Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Gattinoni, L. Articles by Restifo, N. P. Search for Related Content PubMed PubMed Citation Articles by Gattinoni, L. Articles by Restifo, N. P. Related Collections Related Article Social Bookmarking                      What's this?

¹ Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD 20892
² Howard Hughes Medical Institute, NIH Research Scholars Program, Bethesda, MD 20814
³ Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037

CORRESPONDENCE Nicholas P. Restifo: restifo{at}nih.gov

Depletion of immune elements before adoptive cell transfer (ACT) can dramatically improve the antitumor efficacy of transferred CD8⁺ T cells, but the specific mechanisms that contribute to this enhanced immunity remain poorly defined. Elimination of CD4⁺CD25⁺ regulatory T (T reg) cells has been proposed as a key mechanism by which lymphodepletion augments ACT-based immunotherapy. We found that even in the genetic absence of T reg cells, a nonmyeloablative regimen substantially augmented CD8⁺ T cell reactivity to self-tissue and tumor. Surprisingly, enhanced antitumor efficacy and autoimmunity was caused by increased function rather than increased numbers of tumor-reactive T cells, as would be expected by homeostatic mechanisms. The _C cytokines IL-7 and IL-15 were required for augmenting T cell functionality and antitumor activity. Removal of _C cytokine–responsive endogenous cells using antibody or genetic means resulted in the enhanced antitumor responses similar to those seen after nonmyeloablative conditioning. These data indicate that lymphodepletion removes endogenous cellular elements that act as sinks for cytokines that are capable of augmenting the activity of self/tumor-reactive CD8⁺ T cells. Thus, the restricted availability of homeostatic cytokines can be a contributing factor to peripheral tolerance, as well as a limiting resource for the effectiveness of tumor-specific T cells.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Article

Cytokine-robbing cells

Heather L. Van Epps
J. Exp. Med. 2005 202: 883. [Full Text] [PDF]

This article has been cited by other articles:

• Saini, M., Pearson, C., Seddon, B. (2009). Regulation of T cell-dendritic cell interactions by IL-7 governs T-cell activation and homeostasis. Blood 113: 5793-5800 [Abstract] [Full Text]  
• Brunstein, C. G., Wagner, J. E., Weisdorf, D. J., Cooley, S., Noreen, H., Barker, J. N., DeFor, T., Verneris, M. R., Blazar, B. R., Miller, J. S. (2009). Negative effect of KIR alloreactivity in recipients of umbilical cord blood transplant depends on transplantation conditioning intensity. Blood 113: 5628-5634 [Abstract] [Full Text]  
• Jing, W., Gershan, J. A., Johnson, B. D. (2009). Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memory. Blood 113: 4449-4457 [Abstract] [Full Text]  
• Rizzuto, G. A., Merghoub, T., Hirschhorn-Cymerman, D., Liu, C., Lesokhin, A. M., Sahawneh, D., Zhong, H., Panageas, K. S., Perales, M.-A., Altan-Bonnet, G., Wolchok, J. D., Houghton, A. N. (2009). Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response. JEM 206: 849-866 [Abstract] [Full Text]  
• Louis, C. U., Straathof, K., Bollard, C. M., Gerken, C., Huls, M. H., Gresik, M. V., Wu, M.-F., Weiss, H. L., Gee, A. P., Brenner, M. K., Rooney, C. M., Heslop, H. E., Gottschalk, S. (2009). Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients. Blood 113: 2442-2450 [Abstract] [Full Text]  
• Salem, M. L., Diaz-Montero, C. M., Al-Khami, A. A., El-Naggar, S. A., Naga, O., Montero, A. J., Khafagy, A., Cole, D. J. (2009). Recovery from Cyclophosphamide-Induced Lymphopenia Results in Expansion of Immature Dendritic Cells Which Can Mediate Enhanced Prime-Boost Vaccination Antitumor Responses In Vivo When Stimulated with the TLR3 Agonist Poly(I:C). J. Immunol. 182: 2030-2040 [Abstract] [Full Text]  
• Kim, Y. H., Choi, B. K., Oh, H. S., Kang, W. J., Mittler, R. S., Kwon, B. S. (2009). Mechanisms involved in synergistic anticancer effects of anti-4-1BB and cyclophosphamide therapy. Molecular Cancer Therapeutics 8: 469-478 [Abstract] [Full Text]  
• Dudley, M. E., Rosenberg, S. A. (2009). Clinical Trials Investigating Adoptive Cell Therapy Combined with Lymphodepletion for Patients with Advanced Cancer. Am Soc Clin Oncol Ed Book 2009: 516-520 [Abstract] [Full Text]  
• Mackensen, A. (2009). Adoptive Transfer of Tumor Antigen-specific CD8+ T-cells to Patients with Melanoma: Strategies to Improve Therapeutic Efficacy. Am Soc Clin Oncol Ed Book 2009: 521-524 [Abstract] [Full Text]  
• Mariotti, J., Foley, J., Ryan, K., Buxhoeveden, N., Kapoor, V., Amarnath, S., Fowler, D. H. (2008). Graft rejection as a Th1-type process amenable to regulation by donor Th2-type cells through an interleukin-4/STAT6 pathway. Blood 112: 4765-4775 [Abstract] [Full Text]  
• Boni, A., Muranski, P., Cassard, L., Wrzesinski, C., Paulos, C. M., Palmer, D. C., Gattinoni, L., Hinrichs, C. S., Chan, C.-C., Rosenberg, S. A., Restifo, N. P. (2008). Adoptive transfer of allogeneic tumor-specific T cells mediates effective regression of large tumors across major histocompatibility barriers. Blood 112: 4746-4754 [Abstract] [Full Text]  
• Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., Wunderlich, J., Restifo, N. P., Thomasian, A., Downey, S. G., Smith, F. O., Klapper, J., Morton, K., Laurencot, C., White, D. E., Rosenberg, S. A. (2008). Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens. JCO 26: 5233-5239 [Abstract] [Full Text]  
• Wierzbicki, A., Gil, M., Ciesielski, M., Fenstermaker, R. A., Kaneko, Y., Rokita, H., Lau, J. T., Kozbor, D. (2008). Immunization with a Mimotope of GD2 Ganglioside Induces CD8+ T Cells That Recognize Cell Adhesion Molecules on Tumor Cells. J. Immunol. 181: 6644-6653 [Abstract] [Full Text]  
• Verdeil, G., Marquardt, K., Surh, C. D., Sherman, L. A. (2008). Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy. Proc. Natl. Acad. Sci. USA 105: 16683-16688 [Abstract] [Full Text]  
• de Witte, M. A., Jorritsma, A., Kaiser, A., van den Boom, M. D., Dokter, M., Bendle, G. M., Haanen, J. B. A. G., Schumacher, T. N. M. (2008). Requirements for Effective Antitumor Responses of TCR Transduced T Cells. J. Immunol. 181: 5128-5136 [Abstract] [Full Text]  
• Weber, J. (2008). Overcoming Immunologic Tolerance to Melanoma: Targeting CTLA-4 with Ipilimumab (MDX-010). The Oncologist 13: 16-25 [Abstract] [Full Text]  
• Quezada, S. A., Peggs, K. S., Simpson, T. R., Shen, Y., Littman, D. R., Allison, J. P. (2008). Limited tumor infiltration by activated T effector cells restricts the therapeutic activity of regulatory T cell depletion against established melanoma. JEM 205: 2125-2138 [Abstract] [Full Text]  
• King, J., Waxman, J., Stauss, H. (2008). Advances in tumour immunotherapy. QJM 101: 675-683 [Abstract] [Full Text]  
• Wallace, A., Kapoor, V., Sun, J., Mrass, P., Weninger, W., Heitjan, D. F., June, C., Kaiser, L. R., Ling, L. E., Albelda, S. M. (2008). Transforming Growth Factor-{beta} Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers. Clin. Cancer Res. 14: 3966-3974 [Abstract] [Full Text]  
• Palmer, D. C., Chan, C.-C., Gattinoni, L., Wrzesinski, C., Paulos, C. M., Hinrichs, C. S., Powell, D. J. Jr., Klebanoff, C. A., Finkelstein, S. E., Fariss, R. N., Yu, Z., Nussenblatt, R. B., Rosenberg, S. A., Restifo, N. P. (2008). From the Cover: Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc. Natl. Acad. Sci. USA 105: 8061-8066 [Abstract] [Full Text]  
• Jorritsma, A., Bins, A. D., Schumacher, T. N.M., Haanen, J. B.A.G. (2008). Skewing the T-Cell Repertoire by Combined DNA Vaccination, Host Conditioning, and Adoptive Transfer. Cancer Res. 68: 2455-2462 [Abstract] [Full Text]  
• Suzuki, T., Ogawa, S., Tanabe, K., Tahara, H., Abe, R., Kishimoto, H. (2008). Induction of Antitumor Immune Response by Homeostatic Proliferation and CD28 Signaling. J. Immunol. 180: 4596-4605 [Abstract] [Full Text]  
• Calzascia, T., Pellegrini, M., Lin, A., Garza, K. M., Elford, A. R., Shahinian, A., Ohashi, P. S., Mak, T. W. (2008). CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc. Natl. Acad. Sci. USA 105: 2999-3004 [Abstract] [Full Text]  
• Mirmonsef, P., Tan, G., Zhou, G., Morino, T., Noonan, K., Borrello, I., Levitsky, H. I. (2008). Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation. Blood 111: 2112-2121 [Abstract] [Full Text]  
• Heimberger, A. B., Sun, W., Hussain, S. F., Dey, M., Crutcher, L., Aldape, K., Gilbert, M., Hassenbusch, S. J., Sawaya, R., Schmittling, B., Archer, G. E., Mitchell, D. A., Bigner, D. D., Sampson, J. H. (2008). Immunological responses in a patient with glioblastoma multiforme treated with sequential courses of temozolomide and immunotherapy: Case study. Neuro Oncol 10: 98-103 [Abstract] [Full Text]  
• Mariotti, J., Foley, J., Jung, U., Borenstein, T., Kantardzic, N., Han, S., Hanson, J. T., Wong, E., Buxhoeveden, N., Trepel, J. B., Fojo, A. T., Telford, W., Fowler, D. H. (2008). Ex Vivo Rapamycin Generates Apoptosis-Resistant Donor Th2 Cells That Persist In Vivo and Prevent Hemopoietic Stem Cell Graft Rejection. J. Immunol. 180: 89-105 [Abstract] [Full Text]  
• Strauss, L., Bergmann, C., Gooding, W., Johnson, J. T., Whiteside, T. L. (2007). The Frequency and Suppressor Function of CD4+CD25highFoxp3+ T Cells in the Circulation of Patients with Squamous Cell Carcinoma of the Head and Neck. Clin. Cancer Res. 13: 6301-6311 [Abstract] [Full Text]  
• Kochenderfer, J. N., Gress, R. E. (2007). A Comparison and Critical Analysis of Preclinical Anticancer Vaccination Strategies. Exp. Biol. Med. 232: 1130-1141 [Abstract] [Full Text]  
• Miller, J. S., Weisdorf, D. J., Burns, L. J., Slungaard, A., Wagner, J. E., Verneris, M. R., Cooley, S., Wangen, R., Fautsch, S. K., Nicklow, R., DeFor, T., Blazar, B. R. (2007). Lymphodepletion followed by donor lymphocyte infusion (DLI) causes significantly more acute graft-versus-host disease than DLI alone. Blood 110: 2761-2763 [Abstract] [Full Text]  
• Paulos, C. M., Kaiser, A., Wrzesinski, C., Hinrichs, C. S., Cassard, L., Boni, A., Muranski, P., Sanchez-Perez, L., Palmer, D. C., Yu, Z., Antony, P. A., Gattinoni, L., Rosenberg, S. A., Restifo, N. P. (2007). Toll-like Receptors in Tumor Immunotherapy. Clin. Cancer Res. 13: 5280-5289 [Abstract] [Full Text]  
• Pittet, M. J., Grimm, J., Berger, C. R., Tamura, T., Wojtkiewicz, G., Nahrendorf, M., Romero, P., Swirski, F. K., Weissleder, R. (2007). In vivo imaging of T cell delivery to tumors after adoptive transfer therapy. Proc. Natl. Acad. Sci. USA 104: 12457-12461 [Abstract] [Full Text]  
• Kochenderfer, J. N., Simpson, J. L., Chien, C. D., Gress, R. E. (2007). Vaccination regimens incorporating CpG-containing oligodeoxynucleotides and IL-2 generate antigen-specific antitumor immunity from T-cell populations undergoing homeostatic peripheral expansion after BMT. Blood 110: 450-460 [Abstract] [Full Text]  
• Perez-Diez, A., Joncker, N. T., Choi, K., Chan, W. F. N., Anderson, C. C., Lantz, O., Matzinger, P. (2007). CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood 109: 5346-5354 [Abstract] [Full Text]  
• Smeltz, R. B. (2007). Profound Enhancement of the IL-12/IL-18 Pathway of IFN-{gamma} Secretion in Human CD8+ Memory T Cell Subsets via IL-15. J. Immunol. 178: 4786-4792 [Abstract] [Full Text]  
• Condomines, M., Hose, D., Raynaud, P., Hundemer, M., De Vos, J., Baudard, M., Moehler, T., Pantesco, V., Moos, M., Schved, J.-F., Rossi, J.-F., Reme, T., Goldschmidt, H., Klein, B. (2007). Cancer/Testis Genes in Multiple Myeloma: Expression Patterns and Prognosis Value Determined by Microarray Analysis. J. Immunol. 178: 3307-3315 [Abstract] [Full Text]  
• Bracci, L., Moschella, F., Sestili, P., La Sorsa, V., Valentini, M., Canini, I., Baccarini, S., Maccari, S., Ramoni, C., Belardelli, F., Proietti, E. (2007). Cyclophosphamide Enhances the Antitumor Efficacy of Adoptively Transferred Immune Cells through the Induction of Cytokine Expression, B-Cell and T-Cell Homeostatic Proliferation, and Specific Tumor Infiltration. Clin. Cancer Res. 13: 644-653 [Abstract] [Full Text]  
• Thanarajasingam, U., Sanz, L., Diaz, R., Qiao, J., Sanchez-Perez, L., Kottke, T., Thompson, J., Chester, J., Vile, R. G. (2007). Delivery of CCL21 to Metastatic Disease Improves the Efficacy of Adoptive T-Cell Therapy. Cancer Res. 67: 300-308 [Abstract] [Full Text]  
• Gattinoni, L., Ranganathan, A., Surman, D. R., Palmer, D. C., Antony, P. A., Theoret, M. R., Heimann, D. M., Rosenberg, S. A., Restifo, N. P. (2006). CTLA-4 dysregulation of self/tumor-reactive CD8+ T-cell function is CD4+ T-cell dependent. Blood 108: 3818-3823 [Abstract] [Full Text]  
• Mackensen, A., Meidenbauer, N., Vogl, S., Laumer, M., Berger, J., Andreesen, R. (2006). Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients With Metastatic Melanoma. JCO 24: 5060-5069 [Abstract] [Full Text]  
• Powell, D. J. Jr., Dudley, M. E., Hogan, K. A., Wunderlich, J. R., Rosenberg, S. A. (2006). Adoptive Transfer of Vaccine-Induced Peripheral Blood Mononuclear Cells to Patients with Metastatic Melanoma following Lymphodepletion. J. Immunol. 177: 6527-6539 [Abstract] [Full Text]  
• Doyle, H. A., Zhou, J., Wolff, M. J., Harvey, B. P., Roman, R. M., Gee, R. J., Koski, R. A., Mamula, M. J. (2006). Isoaspartyl Post-translational Modification Triggers Anti-tumor T and B Lymphocyte Immunity. J. Biol. Chem. 281: 32676-32683 [Abstract] [Full Text]  
• Morgan, R. A., Dudley, M. E., Wunderlich, J. R., Hughes, M. S., Yang, J. C., Sherry, R. M., Royal, R. E., Topalian, S. L., Kammula, U. S., Restifo, N. P., Zheng, Z., Nahvi, A., de Vries, C. R., Rogers-Freezer, L. J., Mavroukakis, S. A., Rosenberg, S. A. (2006). Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes. Science 314: 126-129 [Abstract] [Full Text]  
• Bourgeois, C., Stockinger, B. (2006). CD25+CD4+ Regulatory T Cells and Memory T Cells Prevent Lymphopenia-Induced Proliferation of Naive T Cells in Transient States of Lymphopenia. J. Immunol. 177: 4558-4566 [Abstract] [Full Text]  
• Smith, C., Cooper, L., Burgess, M., Rist, M., Webb, N., Lambley, E., Tellam, J., Marlton, P., Seymour, J. F., Gandhi, M., Khanna, R. (2006). Functional Reversion of Antigen-Specific CD8+ T Cells from Patients with Hodgkin Lymphoma following In Vitro Stimulation with Recombinant Polyepitope. J. Immunol. 177: 4897-4906 [Abstract] [Full Text]  
• Antony, P. A., Paulos, C. M., Ahmadzadeh, M., Akpinarli, A., Palmer, D. C., Sato, N., Kaiser, A., Heinrichs, C., Klebanoff, C. A., Tagaya, Y., Restifo, N. P. (2006). Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo. J. Immunol. 176: 5255-5266 [Abstract] [Full Text]  
• Rosenberg, S. A., Restifo, N. P. (2006). Response to Comment on "Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma".. J. Immunol. 176: 4511-4512 [Full Text]  
• Lizee, G., Radvanyi, L. G., Overwijk, W. W., Hwu, P. (2006). Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.. Clin. Cancer Res. 12: 2359s-2365s [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS